Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Jun 2026 and Jul 2026.
- Largest single sale: $10.1M (112,422 shares) of BridgeBio Pharma, Inc. on Jul 9, 2026. Filing
- Last sale before this period: Dec 4, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Jazz Pharmaceuticals plc (JAZZ) | Director | Mar 1, 2021 | Sep 2, 2026 |
| BridgeBio Pharma, Inc. (BBIO) | Director | Dec 16, 2019 | Jul 13, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Jazz Pharmaceuticals plc: 1,706 shares withheld by the company for taxes. 1 filing: 1
- Aug 5, 2026, Jazz Pharmaceuticals plc: 1,605 shares granted. 1 filing: 1
- Jul 9, 2026, BridgeBio Pharma, Inc.: sold 148,589 shares for $13.2M, under a disclosed plan; 148,589 shares acquired by exercising options. 1 filing: 1
- Jun 24, 2026, BridgeBio Pharma, Inc.: sold 37,167 shares for $2.6M, under a disclosed plan; 37,167 shares acquired by exercising options. 1 filing: 1
- Jun 23, 2026, BridgeBio Pharma, Inc.: sold 2,196 shares for $151K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.